Testosterone products: increased risk of CV disorders

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1588卷 / 1期

关键词：

D O I：

10.1007/s40278-016-14595-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[31] No increased risk of CV events with long-term antidepressants
Reactions Weekly, 2016, 1595 (1) : 12 - 12
[32] Hypospadias and increased risk for neurodevelopmental disorders
Butwicka, Agnieszka
Lichtenstein, Paul
Landen, Mikael
Nordenvall, Anna S.
Nordenstrom, Anna
Nordenskjold, Agneta
Frisen, Louise
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2015, 56 (02) : 155 - 161
[33] Methotrexate: no increased risk of lung disorders
Reactions Weekly, 2015, 1545 (1) : 10 - 10
[34] Statins: increased risk of musculoskeletal disorders
Reactions Weekly, 2018, 1705 (1) : 9 - 9
[35] Sleep disorders and increased risk of dementia
Ferini-Strambi, Luigi
EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (12) : 3484 - 3485
[36] Inhaled anticholinergics: increased risk of major adverse CV events?
Reactions Weekly, 2008, 1222 (1) : 3 - 3
[37] Significantly increased CV Risk after COVID-19
Franke, Katharina
AKTUELLE KARDIOLOGIE, 2021, 10 (06) : 486 - 486
[38] Cryptorchidism and increased risk of neurodevelopmental disorders
Chen, Jianping
Sorensen, Henrik Toft
Miao, Maohua
Liang, Hong
Ehrenstein, Vera
Wang, Ziliang
Yuan, Wei
Li, Jiong
JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 96 : 153 - 161
[39] COX-2 inhibitors: increased risk of CV events?
Reactions Weekly, 2001, 867 (1) : 2 - 2
[40] Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke Editorial Comment
Seftel, Allen D.
JOURNAL OF UROLOGY, 2015, 194 (03): : 759 - 760

← 1 2 3 4 5 →